Search tips
ESCMID Global 2024
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
28 April 2013 - P1527
Susceptibility of Gram-positive and Gram-negative anaerobic pathogens isolated from patients in Europe with intra-abdominal infections; TEST Program 2011
Doug Biedenbach, D. Biedenbach*, S. Bouchillon, M. Hackel, S. Hawser, D. Hoban, R. Badal, J. Johnson, H. Leister-Tebbe (Schaumburg, US; Epalinges, CH; Collegeville, US)
28 April 2013 - P1532
Trend analysis of tigecycline and comparator agents against bacterial isolates collected in Europe; TEST Program 2004-2011
Doug Biedenbach, M. Hackel*, S. Hawser, D. Hoban, D. Biedenbach, R. Badal, S. Bouchillon, J. Johnson, H. Leister-Tebbe (Schaumburg, US; Epalinges, CH; Collegeville, US)
27 April 2013 - R2582
In vitro activity of tigecycline and comparator agents among Escherichia coli and Klebsiella spp., including extended-spectrum beta-lactamases (ESBL)-producing isolates from Nordic countries: TEST program 2004-2011
Doug Biedenbach, D. Biedenbach*, I. Morrissey, M. Hackel, D. Hoban, S. Bouchillon, B. Johnson, H. Leister-Tebbe (Schaumburg, US; Epalinges, CH; Collegeville, US)
27 April 2013 - R2580
Evolution of resistance trends among Klebsiella pneumoniae and Escherichia coli isolates collected from hospitals in Greece; TEST program 2004-2011
Doug Biedenbach, M. Hackel*, I. Morrissey, S. Hawser, D. Biedenbach, R. Badal, S. Bouchillon, J. Johnson, H. Leister-Tebbe (Schaumburg, US; Epalinges, CH; Collegeville, US)
27 April 2013 - R2581
Activity of tigecycline and comparator agents among Gram-positive and Gram-negative pathogens in France; the TEST Program 2006-2012
Doug Biedenbach, M. Hackel*, S. Hawser, D. Hoban, D. Biedenbach, R. Badal, S. Bouchillon, J. Johnson, H. Leister-Tebbe (Schaumburg, US; Epalinges, CH; Collegeville, US)
27 April 2013 - R2577
Antimicrobial resistance in Eastern European countries among Gram-negative pathogens isolated from intra-abdominal infections: 2004-2011
Doug Biedenbach, D. Hoban*, M. Hackel, R. Badal, S. Bouchillon, B. Johnson, J. Johnson, D. Biedenbach, S. Hawser, H. Leister-Tebbe (Schaumburg, US; Epalinges, CH; Collegeville, US)
02 April 2012 - P1816
Comparison of antimicrobial susceptibility of Acinetobacter baumannii from European inpatient and outpatient isolates: TEST 2007-2011
Brian Johnson, M. Hackel*, S. Hawser, B. Johnson, R. Badal, S. Bouchillon, J. Johnson, M. Dowzicky (Schaumburg, US; Epalinges, CH; Collegeville, US)
01 April 2012 - P1111
Monitoring the activity of antimicrobials against multidrug-resistant Clostridium spp.
Brian Johnson, S. Hawser*, C. Zampaloni, F. Monti, S. Bouchillon, M. Hackel, M. Dowzicky (Schaumburg, US; Epalinges, CH; Collegeville, US)
01 April 2012 - P1208
Reduced carbapenem susceptibility in the Bacteroides fragilis group – findings from the TEST programme 2007-2010
Brian Johnson, M. Hackel*, S. Bouchillon, R. Badal, S. Hawser, D. Hoban, M. Dowzicky (Schaumburg, US; Epalinges, CH; Collegeville, US)
01 April 2012 - P1485
In vitro activity of tigecycline against commonly-isolated pathogens of skin and skin structure infections in Europe: TEST 2009-2010
Brian Johnson, S. Bouchillon*, M. Hackel, D. Hoban, R. Badal, S. Hawser, M. Dowzicky (Schaumburg, US; Epalinges, CH; Collegeville, US)
01 April 2012 - P1487
Trends in tigecycline activity against Gram-negative respiratory pathogens: Asia/Pacific 2004-2010
Brian Johnson, M. Hackel*, D. Hoban, S. Bouchillon, J. Johnson, S. Hawser, M. Dowzicky (Schaumburg, US; Epalinges, CH; Collegeville, US)
01 April 2012 - P1209
An age analysis of the susceptibility of Gram-positive and Gram-negative pathogens from centres in the USA: TEST programme 2008-2010
Brian Johnson, D. Hoban*, S. Hawser, M. Hackel, S. Bouchillon, B. Johnson, J. Johnson, M. Dowzicky (Schaumburg, US; Epalinges, CH; Collegeville, US)
01 April 2012 - P1483
In vitro activity of tigecycline against Streptococcus pneumoniae in the United States: TEST 2009-2010
Brian Johnson, S. Bouchillon*, S. Hawser, C. Zampaloni, M. Hackel, B. Johnson, D. Hoban, M. Dowzicky (Schaumburg, US; Epalinges, CH; Collegeville, US)
01 April 2012 - P1488
In vitro activity of tigecycline against Gram-negative species in Spain: TEST 2009-2010
Brian Johnson, M. Renteria*, S. Hawser, S. Bouchillon, J. Johnson, C. Zampaloni, F. Monti, M. Dowzicky (Schaumburg, US; Epalinges, CH; Collegeville, US)
01 April 2012 - P1178
Prevalence of extended-spectrum beta-lactamases in Europe: 2004-2011
Brian Johnson, M. Hackel*, D. Hoban, R. Badal, S. Bouchillon, B. Johnson, J. Johnson, S. Hawser, M. Dowzicky (Schaumburg, US; Epalinges, CH; Collegeville, US)
01 April 2012 - P1486
Tigecycline and comparators activity in vitro against multidrug-resistant Gram-negative bacteria in Latin America collected in 2007-2010
Brian Johnson, M. Renteria*, M. Hackel, S. Bouchillon, D. Hoban, B. Johnson, R. Badal, S. Hawser, M. Dowzicky (Schaumburg, US; Epalinges, CH; Collegeville, US)
01 April 2012 - P1477
In vitro activity of tigecycline against pathogens from UK/Ireland: TEST 2008-2011
Brian Johnson, B. Johnson*, S. Hawser, C. Zampaloni, M. Hackel, S. Bouchillon, D. Hoban, J. Johnson, R. Badal, M. Dowzicky (Schaumburg, US; Epalinges, CH; Collegeville, US)
Loading ...
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.